Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 1/2 1

Status

Active not recruiting 13Recruiting 7Completed 7Terminated 2Not yet recruiting 2Suspended 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1CNS 1

Conditions

Urinary Bladder Neoplasms 1Advanced Glioblastoma 1

Interventions

Specimen Handling 21Magnetic Resonance Spectroscopy 18Carboplatin 17Gemcitabine 15Cisplatin 12pembrolizumab 11Paclitaxel 11Injections 11Interviews as Topic 10fludarabine 9Radiotherapy 8Oxaliplatin 8Nivolumab 8Fluorouracil 8Dexamethasone 8Cyclophosphamide 8Irinotecan 7Bortezomib 7Biopsy 7Bevacizumab 7toripalimab 6Radiosurgery 6Pemetrexed 6Leucovorin 5Capecitabine 5130-nm albumin-bound paclitaxel 5trastuzumab deruxtecan 4liposomal doxorubicin 4cemiplimab 4X-Rays 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Radiotherapy, Intensity-Modulated × 30 days × Clear all
NCT07605364 2026-05-26

Testing the Addition of an Anti-Cancer Drug, Mycophenolate Mofetil, to the Usual Treatment (Radiation Therapy and Temozolomide) for Advanced Brain Cancer

Alliance for Clinical Trials in Oncology

Phase 2/3 Not yet recruiting
422 enrolled
CNS

Advanced Glioblastoma

NCT07579195 2026-05-14

Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial

University of Washington

Phase 1/2 Not yet recruiting
12 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡